arrow
J

Jennifer M. Giltnane

Genentech
H指数:37
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2− locally-advanced or metastatic breast cancer

腔内细胞系丢失驱动经治ER+ HER2−局部晚期或转移性乳腺癌对下一代ERα拮抗剂的耐药性

2026-04-010
OAAI
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

非小细胞肺癌分子亚型和免疫治疗组合的脆弱性

2025-12-030
OAAI
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis

SPEX:一个模块化的端到端平台,用于高通量组织空间组学分析

2025-08-290
OAAI
Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials

数字与人工PD-L1评分在晚期非小细胞肺癌中的应用比较:基于IMpower110和IMpower150试验

2025-08-050
PRE
ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER+ breast cancer

由ESR1突变和疗法压力导致的ERα功能失调促进了ER阳性乳腺癌的谱系可塑性

2025-01-130
PRE
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer

基于图像的癌症组织多重免疫分析: 翻译意义。国际乳腺癌免疫肿瘤学生物标志物工作组的报告

2024-01-173
OA
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

基于机器学习的乳腺癌肿瘤浸润淋巴细胞评估中的陷阱: 国际免疫肿瘤学生物标志物工作组的报告

2023-08-2312
OAAI
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
2023-06-015
OAAI
Digital pathology based prognostic & predictive biomarkers in metastatic non-small cell lung cancer
2023-04-040
PRE
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2-) advanced/metastatic breast cancer
2022-11-1912
OAAI
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER plus Breast Cancer
2021-07-1284
PREAI